Differences in how respiratory syncytial virus affects cells
Author Information
Author(s): Villenave Rémi, O'Donoghue Dara, Thavagnanam Surendran, Touzelet Olivier, Skibinski Grzegorz, Heaney Liam G, McKaigue James P, Coyle Peter V, Shields Michael D, Power Ultan F
Primary Institution: Centre for Infection & Immunity, School of Medicine, Dentistry & Biomedical Sciences, Queens University Belfast
Hypothesis
Prototypic RSV strains may not accurately represent recent clinical isolates in terms of virus/host interactions in primary human bronchial epithelial cells.
Conclusion
The prototypic RSV strain A2 is poorly representative of recent clinical isolates in terms of cytopathogenicity, viral growth kinetics, and pro-inflammatory responses.
Supporting Evidence
- RSV A2 caused more cytopathic effects than the clinical isolates.
- RSV A2 grew faster and to higher titers in PBECs compared to clinical isolates.
- Increased secretion of IP-10 and RANTES was observed following A2 infection.
Takeaway
This study found that a common lab strain of a virus that causes respiratory illness in infants behaves very differently than newer strains from sick children, which could change how we study the virus.
Methodology
The study isolated three RSV strains from infants and compared them with the prototypic RSV A2 in terms of cytopathology, virus growth kinetics, and chemokine secretion in infected PBEC monolayers.
Potential Biases
Potential bias in the selection of clinical isolates and the limited sample size may affect the generalizability of the findings.
Limitations
The study primarily focused on a limited number of clinical isolates and may not represent all strains of RSV.
Participant Demographics
Children aged 1-11 years undergoing elective surgery, clinically free of viral infections.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website